Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Ascendiant Capital raised the price target for Knightscope, Inc. (NASDAQ:KSCP) from $25 to $26. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Knightscope shares closed at $3.40 on Tuesday. See how other analysts view this stock.
- BTIG increased Kirby Corporation (NYSE:KEX) price target from $135 to $160. BTIG analyst Gregory Lewis maintained a Buy rating. Kirby shares closed at $142.63 on Tuesday. See how other analysts view this stock.
- HC Wainwright & Co cut price target for Vor Biopharma Inc. (NASDAQ:VOR) from $32 to $31. HC Wainwright & Co. analyst Swayampakula Ramakanth maintained a Buy rating. Vor Biopharma shares closed at $15.87 on Tuesday. See how other analysts view this stock.
- Baird slashed the price target for Microsoft Corp (NASDAQ:MSFT) from $540 to $500. Baird analyst William Power maintained an Outperform rating. Microsoft shares closed at $393.11 on Tuesday. See how other analysts view this stock.
- Baird raised CVS Health Corporation (NYSE:CVS) price target from $92 to $94. Baird analyst Michael Ha maintained an Outperform rating. CVS shares closed at $77.62 on Tuesday. See how other analysts view this stock.
- BTIG cut CoStar Group, Inc. (NASDAQ:CSGP) price target from $60 to $55. BTIG analyst Jake Fuller maintained a Buy rating. CoStar shares closed at $37.60 on Tuesday. See how other analysts view this stock.
- B of A Securities raised Dominion Energy, Inc. (NYSE:D) price target from $63 to $65. B of A Securities analyst Julien Dumoulin-Smith maintained a Neutral rating. Dominion Energy shares closed at $63.71 on Tuesday. See how other analysts view this stock.
- Cantor Fitzgerald cut the price target for Klaviyo, Inc. (NASDAQ:KVYO) from $35 to $28. Cantor Fitzgerald analyst Matthew Vanvliet maintained an Overweight rating. Klaviyo shares closed at $16.04 on Tuesday. See how other analysts view this stock.
- Wedbush raised Oruka Therapeutics, Inc. (NASDAQ:ORKA) price target from $45 to $85. Wedbush analyst Martin Fan maintained an Outperform rating. Oruka Therapeutics shares closed at $67.06 on Tuesday. See how other analysts view this stock.
- Baird cut Lucid Group Inc (NASDAQ:LCID) price target from $14 to $12. Baird analyst Ben Kallo maintained a Neutral rating. Lucid Group shares closed at $8.80 on Tuesday. See how other analysts view this stock.
Considering buying MSFT stock? Here’s what analysts think:
Photo via Shutterstock
Login to comment